Glycosylation as a regulator of site-specific metastasis

Wendy E Bindeman1, Barbara Fingleton2

  • 1Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.

Cancer Metastasis Reviews
|December 30, 2021
PubMed

Insights

Glycosylation, the addition of sugars to proteins, significantly impacts cancer metastasis. Altered glycosylation patterns influence cancer cell spread to specific organs like bone, lung, brain, and lymph nodes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Metastasis causes 90% of cancer deaths, with varied patterns based on primary tumor type.
  • Molecular mechanisms of site-specific metastasis are under active investigation.
  • Glycosylation, a common post-translational modification, influences cell-cell interactions and tumor-microenvironment dynamics.

Purpose of the Study:

  • To review the current understanding of glycosylation's role in cancer cell tropism.
  • To explore how glycosylation influences metastasis to specific sites.

Main Methods:

  • Literature review of studies on glycosylation and cancer metastasis.
  • Analysis of research on site-specific metastatic patterns.

Main Results:

  • Altered glycosylation patterns influence cancer metastasis globally and site-specifically.
  • Glycosylation affects cancer cell interactions with various metastatic sites.

Conclusions:

  • Glycosylation is a key mediator in the site-specific spread of cancer.
  • Understanding glycosylation mechanisms can reveal new therapeutic targets for metastasis.

Related Concept Videos

Protein Glycosylation01:25

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
7.6K
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
3.1K
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.1K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K